JFG
LEGN icon

Jefferies Financial Group’s Legend Biotech LEGN Stock Holding History

Jefferies Financial Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$217K – 2003
2025
Q4 		$217K Buy
+10,000
New +$286K ﹤0.01% 1597
2024
Q4 		– Sell
-7,500
Closed -$365K – 1714
2024
Q3 		$365K Sell
7,500
-9,000
-55% -$479K ﹤0.01% 1068
2024
Q2 		$731K Buy
+16,500
New +$761K 0.01% 847
2024
Q1 		– Sell
-19,250
Closed -$1.16M – 1839
2023
Q4 		$1.16M Buy
+19,250
New +$1.22M 0.01% 889

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jefferies Financial Group's LEGN Position: Q1 2026 in Review

Jefferies Financial Group sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 10,000 shares — an estimated $217K sold.

Jefferies Financial Group first reported a position in LEGN in Q4 2023 and held it in 4 quarters. The position peaked at $1.16M in Q4 2023. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Jefferies Financial Group reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 10,000 Legend Biotech shares in Q1 2026, an estimated $217K.
  • Jefferies Financial Group first reported a position in Legend Biotech in Q4 2023 and held it in 4 quarters.
  • Jefferies Financial Group's Legend Biotech position peaked at $1.16M in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.